Chemical SOP
Microbiology SOP
Warehouse SOP
Manufacturing SOP
Information technology SOP

SYRUP OF IRON, CYANOCOBALAMIN, FOLIC ACID WITH ZINC

Explore CPPs and CQAs of Iron, Cyanocobalamin, Folic Acid with Zinc Syrup for GMP-compliant packaging.

1. Introduction to Batch Packing Record (BPR) of Syrup of Iron, Cyanocobalamin, Folic Acid with Zinc

The Batch Packing Record (BPR) of Syrup of Iron, Cyanocobalamin, Folic Acid with Zinc is an essential pharmaceutical document that provides comprehensive information about the packaging operations, quality control measures, and documentation requirements involved in the final packaging of this nutritional supplement. This syrup contains Ferric Ammonium Citrate, Cyanocobalamin (Vitamin B12), Folic Acid (Vitamin B9), and Zinc Sulphate, which contribute to red blood cell formation, haemoglobin synthesis, and the maintenance of normal physiological functions. Each 15 mL contains Ferric Ammonium Citrate 200 mg (equivalent to 41 mg elemental iron), Cyanocobalamin 7.5 mcg, Folic Acid 1 mg, and Zinc Sulphate 7 mg. The BPR systematically documents essential packaging activities, including packaging material dispensing, line clearance, bulk syrup transfer, bottle filling, sealing, labelling, coding, and final packing. It also records packaging material reconciliation, in-process quality checks, equipment details, batch identification, and personnel responsibilities. Proper implementation of the BPR ensures product traceability, packaging accuracy, regulatory compliance, and adherence to Good Manufacturing Practices (GMP). It helps prevent packaging errors, product mix-ups, and documentation discrepancies. The completed BPR serves as critical evidence for Quality Assurance review, batch release decisions, regulatory inspections, and maintaining consistent pharmaceutical product quality throughout packaging operations.

Skip to PDF content

2. Batch Packing Process Flow Diagram for Syrup of Iron, Cyanocobalamin, Folic Acid with Zinc

The Batch Packing Process Flow Diagram for Syrup of Iron, Cyanocobalamin, Folic Acid with Zinc illustrates the systematic sequence of pharmaceutical packaging operations performed in accordance with Good Manufacturing Practices (GMP). The process ensures accurate filling, proper sealing, correct labelling, product identification, and complete batch traceability.

The packaging process begins with the receipt and verification of approved bulk syrup and packaging materials. Before starting operations, line clearance is performed by authorized personnel to ensure that the packaging area and equipment are clean and free from materials belonging to previous batches. Following line clearance, bottles are prepared according to approved procedures and transferred to the filling machine. The syrup is filled into bottles, with in-process checks performed to verify fill volume and packaging quality. Subsequently, bottles undergo capping, sealing, and applicable leak testing to ensure container closure integrity. The filled bottles are labelled with essential product information, including batch number, manufacturing date, expiry date, and other approved details. Secondary packaging involves cartoning and shipper packing according to approved specifications. Finally, packaging material reconciliation, yield verification, and Batch Packing Record review are performed. Quality Assurance evaluates the completed documentation to confirm compliance with established specifications before authorizing the appropriate batch disposition and finished goods release. This structured process helps maintain product quality, regulatory compliance, packaging accuracy, and patient safety throughout pharmaceutical packaging operations.

3. Critical Process Parameters (CPPs) and Critical Quality Attributes (CQAs) of Syrup of Iron, Cyanocobalamin, Folic Acid with Zinc:

Critical Process Parameters (CPPs) and Critical Quality Attributes (CQAs) play an essential role in ensuring the quality, safety, consistency, and regulatory compliance of Syrup of Iron, Cyanocobalamin, Folic Acid with Zinc during pharmaceutical packaging operations. Effective monitoring and control of these parameters help maintain product integrity and compliance with Good Manufacturing Practices (GMP). Critical Process Parameters (CPPs) are process variables whose variability can affect critical quality attributes and therefore require appropriate monitoring or control. Important packaging parameters may include filling machine settings, filling speed, capping torque, sealing conditions, labelling machine adjustments, and equipment operating conditions. Critical Quality Attributes (CQAs) are physical, chemical, biological, or microbiological properties that must remain within established limits to ensure the desired product quality. Relevant attributes include accurate fill volume, container closure integrity, acceptable microbial quality, correct product identification, and compliance with approved packaging specifications.

During syrup filling, appropriate machine settings help ensure consistent fill volumes. Controlled capping and sealing operations maintain container integrity and help prevent leakage or contamination. Proper labelling and coding ensure accurate batch identification, manufacturing dates, expiry dates, and product traceability. In-process inspections, packaging material reconciliation, and Quality Assurance verification further support packaging accuracy and regulatory compliance. Systematic evaluation of CPPs and CQAs through quality risk management, process validation, and routine monitoring helps minimize packaging defects and ensures consistent pharmaceutical product quality.

Note: The criticality of individual parameters and attributes must be justified through product-specific risk assessment, validation, and approved specifications.

error: Content is protected !!

This is the Premium Content

You can access this page after paying the subscription fees of 21 ₹ /month only.